AC Immune SA is a clinical stage biopharmaceutical company advancing a portfolio of programs strategically focused on pioneering Precision Medicine for neurodegenerative diseases. The company uses its proprietary technology platforms to discover, design, and develop novel proprietary small molecules, antibodies, and vaccines for the prevention, diagnosis, and treatment of neurodegenerative diseases associated with protein misfolding. The company has one segment. The company currently focuses mostly of its resources on discovering and developing therapeutic and diagnostic products targeting misfolded proteins. The company's pipeline consists of ACI-24.060, Crenezumab, ACI-35.030, Semorinemab, ACI-7104.056, and others.

What symbol and exchange does Ac Immune SA shares trade?

Ac Immune SA trades on the NASDAQ stock market under the symbol ACIU.

What is Ac Immune SA stock price doing today?

As of November 6, 2026, ACIU stock price climbed to $2.23 with 178,504 million shares trading.

What is Ac Immune SA's Beta?

ACIU has a beta of 0.34, meaning it tends to be less sensitive to market movements. ACIU has a correlation of 0.01 to the broad based SPY ETF.

How much is Ac Immune SA worth?

ACIU has a market cap of $226.96 million. This is considered a Small Cap stock.

How much money does Ac Immune SA make?

Last quarter Ac Immune SA reported $4 million in Revenue and -$.16 earnings per share. This beat revenue expectation by $3 million and exceeded earnings estimates by $.06.

What is the highest and lowest price Ac Immune SA traded in the last 3 year period?

In the last 3 years, ACIU traded as high as $5.14 and as low as $1.43.

What are the top ETFs holding Ac Immune SA?

The top ETF exchange traded funds that ACIU belongs to (by Net Assets): IBB, DFAS, DFMC, DXUV, DFAC.

Is Ac Immune SA (ACIU) a good investment?

ACIU has underperformed the market in the last year with a price return of -35.4% while the SPY ETF gained +10.8%. However, in the short term, ACIU had mixed performance relative to the market. It has outperformed in the last 3 months, returning -3.9% vs -4.1% return in SPY. But in the last 2 weeks, ACIU shares have been beat by the market, returning -7.9% compared to an SPY return of -3.2%.

What are the support and resistance levels for Ac Immune SA (ACIU)?

ACIU support price is $2.01 and resistance is $2.21 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that ACIU shares will trade within this expected range on the day.